Header Logo

Connection

THOMAS MONATH to Helicobacter pylori

Back to Details
This is a "connection" page, showing publications THOMAS MONATH has written about Helicobacter pylori.
THOMAS MONATH
Connection Strength
1.227
Helicobacter pylori
  1. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
    View in: PubMed
    Score: 0.118
  2. Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent. Vaccine. 2001 Sep 14; 19(32):4883-95.
    View in: PubMed
    Score: 0.096
  3. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun. 2000 May; 68(5):2775-82.
    View in: PubMed
    Score: 0.087
  4. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine. 1999 Aug 06; 17(23-24):3072-82.
    View in: PubMed
    Score: 0.083
  5. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine. 1999 Mar 17; 17(11-12):1394-403.
    View in: PubMed
    Score: 0.081
  6. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine. 1999 Mar 17; 17(11-12):1493-505.
    View in: PubMed
    Score: 0.081
  7. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun. 1998 Sep; 66(9):4340-6.
    View in: PubMed
    Score: 0.078
  8. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun. 1998 Jun; 66(6):2879-86.
    View in: PubMed
    Score: 0.077
  9. Vaccine development against infection with Helicobacter pylori. Br Med Bull. 1998; 54(1):229-41.
    View in: PubMed
    Score: 0.074
  10. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology. 1997 Oct; 113(4):1118-28.
    View in: PubMed
    Score: 0.073
  11. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis. 1995 Jul; 172(1):161-72.
    View in: PubMed
    Score: 0.063
  12. Specific immunoglobulin A antibodies in maternal milk and delayed Helicobacter pylori colonization in Gambian infants. Clin Infect Dis. 2004 Oct 15; 39(8):1155-60.
    View in: PubMed
    Score: 0.030
  13. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol. 2003 Nov; 98(11):2395-402.
    View in: PubMed
    Score: 0.028
  14. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis. 2003 Nov 01; 188(9):1263-75.
    View in: PubMed
    Score: 0.028
  15. Safety and efficacy of E coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori. Vaccine. 2002 Dec 13; 21(3-4):194-201.
    View in: PubMed
    Score: 0.026
  16. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut. 2002 Nov; 51(5):634-40.
    View in: PubMed
    Score: 0.026
  17. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun. 2002 Sep; 70(9):5096-106.
    View in: PubMed
    Score: 0.026
  18. Posttreatment follow-up of Helicobacter pylori infection using a stool antigen immunoassay. Clin Diagn Lab Immunol. 2001 Jul; 8(4):718-23.
    View in: PubMed
    Score: 0.024
  19. Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones. FEMS Immunol Med Microbiol. 2001 Mar; 30(2):157-65.
    View in: PubMed
    Score: 0.023
  20. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 1999 Apr; 116(4):804-12.
    View in: PubMed
    Score: 0.020
  21. Serologic IgG response to urease in Helicobacter pylori-infected persons from Mexico. Am J Trop Med Hyg. 1999 Apr; 60(4):587-92.
    View in: PubMed
    Score: 0.020
  22. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998 Dec 21; 188(12):2277-88.
    View in: PubMed
    Score: 0.020
  23. Experimentally induced infection with Helicobacter pylori in squirrel monkeys (Saimiri spp.): clinical, microbiological, and histopathologic findings. Lab Anim Sci. 1998 Jun; 48(3):303-9.
    View in: PubMed
    Score: 0.019
  24. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine. 1997 Mar; 15(4):370-6.
    View in: PubMed
    Score: 0.018
  25. Risk of Helicobacter pylori infection among long-term residents in developing countries. Am J Trop Med Hyg. 1999 Feb; 60(2):267-70.
    View in: PubMed
    Score: 0.005
  26. Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 1996 Jun; 110(6):1770-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.